Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tafenoquine for P. vivax Malaria
NCT01290601Phase 2Terminated
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2003
- Primary completion
- Jan 2005
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tafenoquine in Plasmodium vivax malaria, sponsored by U.S. Army Medical Research and Development Command. Started Sep 2003; status: terminated.
02
Drugs
tafenoquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01290601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290601.